	Complete Response in Metastatic Rectal Cancer with Hepatic and Pulmonary Metastases Treated with Second-Line FOLFIRI plus Ramucirumab: A Case Report. Case Rep Oncol Hasegawa M, Okayama H, Kitabori Y, Yamauchi N, Nakajima T, Matsumoto S, Sato N, Saito M, Kono K. PMID: 42312106 [PubMed]
	A Phase II Trial of Perioperative Camrelizumab Plus Neoadjuvant Chemotherapy in Resectable Stage IIB-IIIB Lung Squamous Cell Carcinoma. MedComm (2020) Hu M, Liu S, Han Y, Wang F, Liu Y, Lu B, Li H, Gao Y, Wang Y, Yang W, Shi K, Xiao B, Wang Q, Du J, Lin H, Li X, Wang C, Zhang T. PMID: 42311860 [PubMed]
	Risk prediction models for postoperative atrial fibrillation in patients with lung cancer: a systematic review and meta-analysis. Front Cardiovasc Med Yang F, Sun T, Shang Y, Chen Y, Wu J, Shang X. PMID: 42311770 [PubMed]
	Current status and trends of immune-related adverse events in lung cancer treated with immune checkpoint inhibitors: a bibliometric analysis of the past decade (2016-2025). Front Immunol Guo B, Zhang G, Sang S, Ma X, Qi H. PMID: 42311664 [PubMed - indexed for MEDLINE]
	Predicting response to immunochemotherapy in EGFR-mutant lung adenocarcinoma after third-generation TKI resistance using CT radiomics-based habitat imaging. Front Immunol Qie S, Shi Y, Li J, Jia S, Yin X. PMID: 42311663 [PubMed - indexed for MEDLINE]
	Multimodal diagnostic network integrating infrared and mass spectra for lung cancer. Biomed Opt Express Huang L, Zhao X, Tian Y, Shao J, Liu G, Wu C. PMID: 42311313 [PubMed]
	Radiomics to understand pre-treatment tumor biology for resectable non-small cell lung cancer. Front Oncol Zollinger B, Pham D, Suzuki K. PMID: 42311254 [PubMed]
	Associations between systemic immune-inflammation index and immune-related hypothyroidism in non-small cell lung cancer patients receiving immune checkpoint inhibitors: a retrospective study. Front Oncol Dai W, Li Q, Wang M, Wang C, Cao H. PMID: 42311250 [PubMed]
	Evaluation of zongertinib for the treatment of metastatic non-squamous non-small cell lung cancer with HER2 TKD activating mutation. Expert Opin Pharmacother Chen M, Gandhib J, Wu S, Cheng H. PMID: 42311064 [PubMed - as supplied by publisher]
	Lung cancer multimodal auxiliary diagnosis based on entropy weight decision fusion. Biomed Eng Online Zhang H, Tang Y, Li P, Fan W, Chen X. PMID: 42310728 [PubMed - as supplied by publisher]
	Preoperative Predictors of Surgical Complexity After Neoadjuvant Immunochemotherapy in Non-small-cell Lung Cancer. Ann Surg Oncol Tane S, Nomura K, Watanabe T, Takamori S, Ohara S, Oiki H, Katsumata S, Takamori S, Nakatsuka M, Tenpaku H, Nakamura R, Notsuda H, Namba K, Minegishi K, Kitamura Y, Abe M, Takegahara K, Konno H, Mizuno K, Toyoda T, Muto S, Toda M, Endo M, Maniwa Y, Soh J, Ohde Y. PMID: 42310265 [PubMed - as supplied by publisher]
	Deep integration of clinical metadata with [(18)F]FDG PET/CT imaging for histological subtyping in non-small cell lung cancer: a multi-center study. Eur J Nucl Med Mol Imaging Zhang J, Zhang X, Wang J, Hao H, Hu D, Hu K, Li X, Li Y, Liu G, Tian R, Wu W, Ma X, Huang Y, Jin C, Zhong Y, Tian M, Zhang H. PMID: 42310216 [PubMed - as supplied by publisher]
	Repeatability of AI-quantified incidental findings on lung cancer screening CT scans in the NELSON trial. Eur Radiol Bunk S, Bruins Slot T, Bennink E, Sidorenkov G, van der Velden N, Schurink N, Lades F, Sebald M, Heuvelmans MA, Gietema HA, Aerts JG, de Bock GH, Schaefer-Prokop C, de Jong PA, Vliegenthart R, Mohamed Hoesein FAA, NELSON-POP consortium. PMID: 42310036 [PubMed - as supplied by publisher]
	Association Between Osimertinib Dose Reduction and Treatment Outcomes in First-Line EGFR-Mutated Advanced NSCLC: The Impact of Post-Progression Management. Thorac Cancer Oi I, Fujita K, Imakita T, Tukino M, Noguchi T, Okada Y, Yoshimura S, Fujimoto N, Toyama S, Watanabe A, Ito T, Kaku R, Kanai O, Ohuchi M, Tanizawa K, Sawai S, Mio T. PMID: 42309786 [PubMed - indexed for MEDLINE]
	Effectiveness of preoperative pulmonary rehabilitation in patients with lung cancer combined with moderate to severe COPD: study protocol for a randomized controlled trial. Respir Med Yang JY, Lv L, Ni J. PMID: 42309231 [PubMed - as supplied by publisher]
	A novel C17-sesquiterpene alkaloid derived from Dendrobium huoshanense: in vitro evaluation of its anti-lung cancer activity and molecular dynamics simulation study. Nat Prod Res Chen J, Li XM, Sun YP, Dai YF, Li SH, Chen NF, Chen ND. PMID: 42308126 [PubMed - as supplied by publisher]
	Artificial Intelligence Is Not a Panacea: LungIMPACT Trial Shows Prioritization Cannot Overcome Systemic Delays in Lung Cancer Diagnosis. AJR Am J Roentgenol Brooks MA. PMID: 42308095 [PubMed - as supplied by publisher]
	A diagnostic nomogram for synchronous lung metastasis at initial diagnosis in osteosarcoma: A retrospective SEER database study. J Orthop Surg (Hong Kong) Ge S, Yu Y, Hu L, Niu Y. PMID: 42307977 [PubMed - indexed for MEDLINE]
	Bispecific Antibody Ivonescimab Added to Chemotherapy in EGFR-Variant Non-Small Cell Lung Cancer: The HARMONi-A Randomized Clinical Trial. JAMA HARMONi-A Study Investigators, Fang W, Zhao Y, Luo Y, Yang R, Huang Y, He Z, Zhao H, Li M, Li K, Song Q, Du X, Sun Y, Li W, Sun L, Wang Z, Yang K, Fan Y, Liu B, Zhao H, Hu Y, Jia L, Xu S, Yi T, Lv D, Lan H, Li M, Liang W, Wang Y, Yang H, Jia Y, Chen Y, Lu J, Shi M, Liu C, Zhou M, Zhou J, Liu X, Zhou N, He M, Dong X, Chen H, Chen Y, Su H, Li X, Zhang Z, Yang L, Liu Y, Chen L, Hou X, Zhang Y, Guo J, Ma R, Lu H, Wu D, Feng W, Li W, Huang J, Wang Y, Song X, Peng J, Liu L, Guo Y, Li W, Xia M, Lu D, Hu M, Wang ZM, Li B, Xia MY, Zhang L. PMID: 42307937 [PubMed - as supplied by publisher]
	Optimal Number of Pleural Biopsies During Pleuroscopy (OPTIBIOP). J Bronchology Interv Pulmonol Bahk J, Duval A, Choi S, Ganjaei K, Beasley MB, Agrawal A, Chaddha U. PMID: 42307772 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 159603

Page 1 of 7981



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy